Steve Hammerton

Steve Hammerton has over 25 years of investment banking and corporate finance experience across Australia, New Zealand and Europe.  Prior to Flagstaff Partners, Steve was a Director with Merrill Lynch in Melbourne & London

Steve has advised major corporate, public sector and financial sponsor clients providing corporate finance, M&A, capital structure and strategic advice. Major transactions and roles include advising Auckland Council on its NZ$830m selldown of Auckland International Airport and the strategic review of the Port of Auckland, the NZ$520m IPO of New Zealand’s Napier Port, the A$500m lease of the Port of Darwin, the restructure of the $11bn Melbourne Metro project for the Victorian Government, and the $3bn IPO of Australia’s electronic lodgement network operator, PEXA

Steven also advised engineering consultancy GHD on its 2014 merger with Canada’s Conestoga-Rovers & Associates, the sale of Norman Disney & Young to Tetra Tech and provided corporate finance advice to Australian urban planning consultancy, Urbis.  In the healthcare sector Steven has advised global biotech leader CSL on asset sales, ratings and corporate finance advice, Ramsay Health Care on its UK acquisitions, and Eczacibasi on its sale to Zentiva

Since 2014 Steve has been a non-executive member of GHD’s Board Finance Committee and is a Director on the Board of Trustees for the Brian M Davis Charitable Foundation in aid of disadvantaged children. Steve holds a Bachelor of Commerce and a Bachelor of Laws (with Honours) from Monash University, is a member of Chartered Accountants Australia & New Zealand (CAANZ) and a Fellow of the Financial Services Institute of Australasia (FINSIA)


Adviser to the Victorian Government on the restructuring of the $10bn Melbourne Metro project (Tunnels & Stations private public partnership)

Adviser to Napier Port and Hawke’s Bay Regional Council on the NZ$520m IPO of Napier Port

Adviser to the Northern Territory Government on the $500m long term lease of the Port of Darwin

Adviser to CSL on the sale of its immunohaematology business to Paragon Care, Australian pharmaceutical contract logistics business to Toll Group, ratings advice and other strategic initiatives

Adviser to GHD on its merger with Conestoga-Rovers & Associates (CRA)

Adviser to Norman Disney & Young on its sale to Tetra Tech

Defence adviser to Pacific Brands on its unsolicited approach by KKR

Adviser to Myer on its $1.5bn proposed merger with David Jones

Adviser to GrainCorp on its $3bn proposed merger with AWB

Adviser to Anchorage Capital Partners on the sale of Total Eden to Ruralco

Adviser on the sale of Decor

Privacy Settings
We use cookies to enhance your experience while using our website. If you are using our Services via a browser you can restrict, block or remove cookies through your web browser settings. We also use content and scripts from third parties that may use tracking technologies. You can selectively provide your consent below to allow such third party embeds. For complete information about the cookies we use, data we collect and how we process them, please check our Privacy Policy
Consent to display content from - Youtube
Consent to display content from - Vimeo
Google Maps
Consent to display content from - Google
Consent to display content from - Spotify
Sound Cloud
Consent to display content from - Sound